Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2023 Apr 3

PMID 37006979

Authors

Yasa Gul Mutlu

Berrin Balik Aydin

Cem Erdogan

Deniz Kizilaslan

Huseyin Saffet Bekoz

Aliihsan Gemici

Leylagul Kaynar

Omur Gokmen Sevindik

Affiliations

Soon will be listed here.

Abstract

Introduction: To identify new clinical and biologic parameters associated with short-term survival in allogeneic or autologous hematopoietic stem cell transplantation (HSCT) patients who were admitted to the intensive care unit (ICU) during their post-transplant period.

Materials And Methods: 40 patients who were admitted to the ICU in our center during their post-transplant period were evaluated retrospectively between Jan 2014 - Jun 2021. Baseline patient characteristics before the transplant, reasons for ICU admissions, laboratory and clinical findings, supportive treatment in ICU and short-term survival were analyzed.

Results: We found 8.8% ICU admission rate in all patient group (n = 450). Mortality rate of the patients who were admitted to ICU was 75%. Invasive mechanic ventilation, need for vasopressor, heart rate was significantly different between survivor and non-survivor group (p = 0.001, p = 0.001, p = 0.004). Elevated INR was associated with poor survival on ICU (p = 0.033). APACHE II score was an independent predictor of ICU mortality (p = 0.045).

Conclusion: Despite the recent advances in transplant conditioning protocols, prophylaxis strategies and improvements of management in ICU, overall survival for HSCT patients in ICU is still poor. In this study INR level was described as a new prognostic factor in ICU for first time in the literature.

References

Soubani A, Kseibi E, Bander J, Klein J, Khanchandani G, Ahmed H . Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest. 2004; 126(5):1604-11. DOI: 10.1378/chest.126.5.1604. View

Agarwal S, ODonoghue S, Gowardman J, Kennedy G, Bandeshe H, Boots R . Intensive care unit experience of haemopoietic stem cell transplant patients. Intern Med J. 2011; 42(7):748-54. DOI: 10.1111/j.1445-5994.2011.02533.x. View

Michel C, Teschner D, Schmidtmann I, Theobald M, Hauptrock B, Wagner-Drouet E . Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization. Sci Rep. 2019; 9(1):19911. PMC: 6934707. DOI: 10.1038/s41598-019-56322-0. View

Trinkaus M, Lapinsky S, Crump M, Keating A, Reece D, Chen C . Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant. 2008; 43(5):411-5. DOI: 10.1038/bmt.2008.336. View

Saillard C, Darmon M, Bisbal M, Sannini A, Chow-Chine L, Faucher M . Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transplant. 2018; 53(10):1233-1241. DOI: 10.1038/s41409-018-0181-x. View

Nakamura M, Fujii N, Shimizu K, Ikegawa S, Seike K, Inomata T . Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol. 2018; 108(6):622-629. DOI: 10.1007/s12185-018-2536-x. View

van der Heiden P, Arbous M, van Beers E, van den Bergh W, le Cessie S, Demandt A . Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation. Bone Marrow Transplant. 2018; 54(3):418-424. DOI: 10.1038/s41409-018-0277-3. View

An K, Wang Y, Li B, Luo C, Wang J, Luo C . Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit. BMC Pediatr. 2016; 16(1):138. PMC: 4992291. DOI: 10.1186/s12887-016-0669-8. View

Sorror M . Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes. Biol Blood Marrow Transplant. 2009; 15(1 Suppl):149-53. DOI: 10.1016/j.bbmt.2008.12.498. View

10.

Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J . Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant. 2010; 46(9):1186-91. DOI: 10.1038/bmt.2010.255. View

11.

van Vliet M, van der Burgt M, van der Velden W, Hoeven J, de Haan A, Donnelly J . Trends in the outcomes of Dutch haematological patients receiving intensive care support. Neth J Med. 2014; 72(2):107-12. View

12.

Townsend W, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone A . Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol. 2013; 161(4):578-86. PMC: 4296346. DOI: 10.1111/bjh.12294. View

13.

Afessa B, Tefferi A, HOAGLAND H, Letendre L, Peters S . Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992; 67(2):117-22. DOI: 10.1016/s0025-6196(12)61310-x. View

14.

Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B . Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2005; 24(4):643-9. DOI: 10.1200/JCO.2005.03.9073. View

15.

Neumann F, Lobitz O, Fenk R, Bruns I, Kostering M, Steiner S . The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol. 2008; 87(4):299-304. DOI: 10.1007/s00277-008-0440-9. View

16.

Diaconescu R, Flowers C, Storer B, Sorror M, Maris M, Maloney D . Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood. 2004; 104(5):1550-8. DOI: 10.1182/blood-2004-03-0804. View

17.

Jackson S, TWEEDDALE M, Barnett M, Spinelli J, Sutherland H, Reece D . Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998; 21(7):697-704. DOI: 10.1038/sj.bmt.1701158. View